Bessemer Group’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$315K Sell
1,098
-1,768
-62% -$507K ﹤0.01% 980
2025
Q1
$884K Sell
2,866
-6,047
-68% -$1.87M ﹤0.01% 742
2024
Q4
$3.15M Sell
8,913
-48
-0.5% -$16.9K 0.01% 549
2024
Q3
$3.21M Buy
8,961
+8,909
+17,133% +$3.19M 0.01% 563
2024
Q2
$17K Hold
52
﹤0.01% 1418
2024
Q1
$12K Sell
52
-4,189
-99% -$967K ﹤0.01% 1525
2023
Q4
$932K Sell
4,241
-427
-9% -$93.8K ﹤0.01% 672
2023
Q3
$1.05M Buy
4,668
+28
+0.6% +$6.32K ﹤0.01% 613
2023
Q2
$1.03M Buy
4,640
+38
+0.8% +$8.39K ﹤0.01% 634
2023
Q1
$1.03M Sell
4,602
-2
-0% -$448 ﹤0.01% 580
2022
Q4
$1.28M Buy
4,604
+30
+0.7% +$8.34K ﹤0.01% 531
2022
Q3
$958K Buy
4,574
+153
+3% +$32K ﹤0.01% 589
2022
Q2
$1.04M Hold
4,421
﹤0.01% 565
2022
Q1
$793K Buy
4,421
+1,351
+44% +$242K ﹤0.01% 524
2021
Q4
$663K Buy
3,070
+1,120
+57% +$242K ﹤0.01% 559
2021
Q3
$360K Buy
1,950
+50
+3% +$9.23K ﹤0.01% 642
2021
Q2
$341K Hold
1,900
﹤0.01% 664
2021
Q1
$318K Sell
1,900
-52
-3% -$8.7K ﹤0.01% 651
2020
Q4
$296K Buy
1,952
+52
+3% +$7.89K ﹤0.01% 642
2020
Q3
$192K Sell
1,900
-6,876
-78% -$695K ﹤0.01% 735
2020
Q2
$1.06M Buy
+8,776
New +$1.06M ﹤0.01% 754
2019
Q1
Sell
-109
Closed -$12K 1980
2018
Q4
$12K Hold
109
﹤0.01% 1624
2018
Q3
$14K Buy
+109
New +$14K ﹤0.01% 1551
2017
Q4
Sell
-135
Closed -$16K 1829
2017
Q3
$16K Sell
135
-135
-50% -$16K ﹤0.01% 1530
2017
Q2
$35K Buy
+270
New +$35K ﹤0.01% 1375
2016
Q2
Sell
-8,500
Closed -$947K 1461
2016
Q1
$947K Buy
+8,500
New +$947K 0.01% 474
2015
Q4
Sell
-425
Closed -$56K 1729
2015
Q3
$56K Sell
425
-2
-0.5% -$264 ﹤0.01% 936
2015
Q2
$75K Sell
427
-4,623
-92% -$812K ﹤0.01% 900
2015
Q1
$871K Buy
5,050
+4,650
+1,163% +$802K ﹤0.01% 537
2014
Q4
$52K Sell
400
-11,773
-97% -$1.53M ﹤0.01% 930
2014
Q3
$1.57M Hold
12,173
0.01% 406
2014
Q2
$1.08M Hold
12,173
0.01% 440
2014
Q1
$1.15M Sell
12,173
-130
-1% -$12.2K 0.01% 408
2013
Q4
$1.39M Hold
12,303
0.01% 399
2013
Q3
$970K Sell
12,303
-13,077
-52% -$1.03M 0.01% 417
2013
Q2
$1.67M Buy
+25,380
New +$1.67M 0.02% 316